%0 Journal Article
%T Nationwide use of REBOA in adolescent trauma patients: an analysis of the AAST AORTA registry
%J Injury
%D 2020
%A Theodorou, Christina M.
%A Brenner, Megan
%A Morrison, Jonathan J.
%A Scalea, Thomas M.
%A Moore, Laura J.
%A Cannon, Jeremy
%A Seamon, Mark
%A Dubose, Joseph J.
%A Galante, Joseph M.
%A AAST AORTA Study Group, 
%V ePub
%N ePub
%P ePub-ePub
%X BACKGROUND: Trauma is the leading cause of death for children and adolescents. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive method of hemorrhage control used primarily in adults. We aimed to characterize REBOA use in pediatric patients.   METHODS: The American Association for the Surgery of Trauma (AAST) Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry was queried for patients <18 years old undergoing REBOA placement (2013-2020). The primary outcome was mortality. Secondary outcomes included injury severity score (ISS), additional interventions, and complications.   RESULTS: Eleven patients with a median age of 17 years old had REBOA placed, with a survival rate of 30%. Inflation of the REBOA balloon resulted in a significant increase in systolic blood pressure (SBP) (median SBP pre-REBOA 53 mmHg vs. post-REBOA 110 mmHg, p=0.0007). Patients were severely injured with a median ISS of 29 (interquartile range 16-42). There were no access-site complications. All three surviving patients had a discharge Glasgow Coma Scale of 15.   CONCLUSION: REBOA is used in patients <18 years old, but all reported patients in this registry were adolescents. No REBOA-related complications were reported. Identifying pediatric patients who may benefit from REBOA and modifying currently existing technology for this group of patients is an area of ongoing research.<p /> <p>Language: en</p>
%G en
%I Elsevier Publishing
%@ 0020-1383
%U http://dx.doi.org/10.1016/j.injury.2020.08.009